Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriyama, T.
Right arrow Articles by Ueda, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriyama, T.
Right arrow Articles by Ueda, N.

Journal of the American Society of Nephrology, Vol 6, 95-101, Copyright © 1995 by American Society of Nephrology


REGULAR ARTICLES

Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells

T Moriyama, M Fujibayashi, Y Fujiwara, T Kaneko, C Xia, E Imai, T Kamada, A Ando and N Ueda
First Department of Medicine, Osaka University School of Medicine, Japan.

Interleukin-6 (IL-6) is a multifunctional cytokine exerting a wide variety of biologic responses, including cell proliferation. Recently, IL-6 has been known to play a role in the pathogenesis of mesangial proliferative glomerulonephritis. IL-6 is now recognized as an autocrine growth factor for glomerular mesangial cells, and various inflammatory mediators have been shown to promote IL-6 release from mesangial cells. However, little is known about the noninflammatory stimuli of IL-6 release from mesangial cells. In this study, it was hypothesized that angiotensin II (AngII) is one of the noninflammatory mediators of IL-6 release in mesangial cells, and the effects of AngII on IL-6 release and mRNA expression in cultured mouse mesangial cells (CMMC) were investigated. It was demonstrated that AngII (10(-7) M or higher) caused IL-6 release and mRNA accumulation in CMMC. IL-6 release was detected at 4 h and reached a plateau at 8 h after the addition of AngII, whereas IL-6 mRNA expression peaked at 4 h. The effects of AngII on IL-6 release and gene expression were completely blocked by the AngII receptor type 1 (AT1 receptor) antagonist CV-11974. AngII and IL- 6 were both shown to stimulate DNA synthesis in CMMC, and the blockade of IL-6 signaling with anti-IL-6 receptor antibody abolished the enhanced DNA synthesis induced by AngII. These results raise a possibility that the growth-promoting effect of AngII on mesangial cells is at least partially mediated by IL-6 released from mesangial cells.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Takeji, T. Moriyama, S. Oseto, N. Kawada, M. Hori, E. Imai, and T. Miwa
Smooth Muscle {alpha}-Actin Deficiency in Myofibroblasts Leads to Enhanced Renal Tissue Fibrosis
J. Biol. Chem., December 29, 2006; 281(52): 40193 - 40200.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Takeji, N. Kawada, T. Moriyama, K. Nagatoya, S. Oseto, S. Akira, M. Hori, E. Imai, and T. Miwa
CCAAT/Enhancer-Binding Protein {delta} Contributes to Myofibroblast Transdifferentiation and Renal Disease Progression
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2383 - 2390.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Skurk, V. van Harmelen, and H. Hauner
Angiotensin II Stimulates the Release of Interleukin-6 and Interleukin-8 From Cultured Human Adipocytes by Activation of NF-{kappa}B
Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1199 - 1203.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Shimizu, M. Miyoshi, K. Matsumoto, O. Goto, T. Imoto, and T. Watanabe
The Effect of Central Injection of Angiotensin-Converting Enzyme Inhibitor and the Angiotensin Type 1 Receptor Antagonist on the Induction by Lipopolysaccharide of Fever and Brain Interleukin-1{beta} Response in Rats
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 865 - 873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Miyoshi, K. Nagata, T. Imoto, O. Goto, A. Ishida, and T. Watanabe
ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1092 - R1097.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
O. Lorenzo, M. Ruiz-Ortega, Y. Suzuki, M. Ruperez, V. Esteban, T. Sugaya, and J. Egido
Angiotensin III Activates Nuclear Transcription Factor-{kappa}B in Cultured Mesangial Cells Mainly via AT2 Receptors: Studies with AT1 Receptor-Knockout Mice
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1162 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Keidar, R. Heinrich, M. Kaplan, T. Hayek, and M. Aviram
Angiotensin II Administration to Atherosclerotic Mice Increases Macrophage Uptake of Oxidized LDL: A Possible Role for Interleukin-6
Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1464 - 1469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, J. Blanco, and J. Egido
Systemic Infusion of Angiotensin II into Normal Rats Activates Nuclear Factor-{{kappa}}B and AP-1 in the Kidney : Role of AT1 and AT2 Receptors
Am. J. Pathol., May 1, 2001; 158(5): 1743 - 1756.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, and J. Egido
ACE inhibitors and AT1 receptor antagonists--beyond the haemodynamic effect
Nephrol. Dial. Transplant., May 1, 2000; 15(5): 561 - 565.
[Full Text] [PDF]


Home page
HypertensionHome page
E. Mervaala, D. N. Muller, J.-K. Park, R. Dechend, F. Schmidt, A. Fiebeler, M. Bieringer, V. Breu, D. Ganten, H. Haller, et al.
Cyclosporin A Protects Against Angiotensin II-Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen Genes
Hypertension, January 1, 2000; 35(1): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Kranzhofer, J. Schmidt, C. A. H. Pfeiffer, S. Hagl, P. Libby, and W. Kubler
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Funakoshi, T. Ichiki, K. Ito, and A. Takeshita
Induction of Interleukin-6 Expression by Angiotensin II in Rat Vascular Smooth Muscle Cells
Hypertension, July 1, 1999; 34(1): 118 - 125.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ruiz-Ortega, C. Bustos, M. A. Hernandez-Presa, O. Lorenzo, J. J. Plaza, and J. Egido
Angiotensin II Participates in Mononuclear Cell Recruitment in Experimental Immune Complex Nephritis Through Nuclear Factor-{kappa}B Activation and Monocyte Chemoattractant Protein-1 Synthesis
J. Immunol., July 1, 1998; 161(1): 430 - 439.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. R. Ferreri, B. A. Escalante, Y. Zhao, S.-J. An, and J. C. McGiff
Angiotensin II induces TNF production by the thick ascending limb: functional implications
Am J Physiol Renal Physiol, January 1, 1998; 274(1): F148 - F155.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sano, K. Fukuda, H. Kodama, J. Pan, M. Saito, J. Matsuzaki, T. Takahashi, S. Makino, T. Kato, and S. Ogawa
Interleukin-6 Family of Cytokines Mediate Angiotensin II-induced Cardiac Hypertrophy in Rodent Cardiomyocytes
J. Biol. Chem., September 15, 2000; 275(38): 29717 - 29723.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP